These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Diagnosis of poliomyelitis by demonstration of intrathecal synthesis of neutralizing antibodies. Hovi T; Stenvik M; Kinnunen E J Infect Dis; 1986 May; 153(5):998-9. PubMed ID: 3009642 [No Abstract] [Full Text] [Related]
67. Simple tests for the diagnosis of picornavirus epidemic conjunctivitis (acute haemorrhagic conjunctivitis). Yin-Murphy M Bull World Health Organ; 1976; 54(6):675-9. PubMed ID: 1088513 [TBL] [Abstract][Full Text] [Related]
68. Prevalence of poliovirus antibodies in healthy children of Ahmedabad. Goel RK; Jhala CI; Chhaya RK; Naik GC; Mehta RC Indian J Pediatr; 1981; 48(390):71-4. PubMed ID: 6268538 [No Abstract] [Full Text] [Related]
69. Conjugation of enzymes to anti-poliovirus globulin: effect of enzyme molecular weight on virus neutralization capacity. Herrmann JE; Morse SA Immunochemistry; 1974 Feb; 11(2):79-82. PubMed ID: 4362769 [No Abstract] [Full Text] [Related]
70. A comparative study of a plaque and quantal method for assaying the neutralizing activity of antisera to type 1 poliovirus. Higgins PG J Hyg (Lond); 1965 Sep; 63(3):311-25. PubMed ID: 4283919 [No Abstract] [Full Text] [Related]
71. Use of blood collected on filter paper disks in neutralization tests for poliovirus antibody. Reed D; Brody JA Public Health Rep (1896); 1965 Dec; 80(12):1100-2. PubMed ID: 4284838 [No Abstract] [Full Text] [Related]
72. Analysis of poliovirus antibody complexes by density gradient centrifugation. Kawanishi M; Ozaki Y Arch Virol; 1978; 57(2):189-94. PubMed ID: 208491 [TBL] [Abstract][Full Text] [Related]
73. Titration and neutralization of poliovirus in micro tissue culture under increased carbon dioxide. Kende M; Robbins ML Appl Microbiol; 1965 Nov; 13(6):1026-9. PubMed ID: 4286244 [TBL] [Abstract][Full Text] [Related]
74. Fetal damage after accidental polio vaccination of an immune mother. Burton AE; Robinson ET; Harper WF; Bell EJ; Boyd JF J R Coll Gen Pract; 1984 Jul; 34(264):390-4. PubMed ID: 6747944 [TBL] [Abstract][Full Text] [Related]
75. Susceptibility of itinerants ("travelling people") in Scotland to poliomyelitis. Bell EJ; Riding MH; Collier PW; Wilson NC; Reid D Bull World Health Organ; 1983; 61(5):839-43. PubMed ID: 6317214 [TBL] [Abstract][Full Text] [Related]
76. Point mutations in polypeptide VP1 of foot-and-mouth disease virus affect mouse virulence and BHK21 cell pathogenicity. Dawe PS; King AM Arch Virol; 1983; 76(2):117-26. PubMed ID: 6307221 [TBL] [Abstract][Full Text] [Related]
77. Routine enterovirus diagnosis in a human rhabdomyosarcoma cell line. Bell EJ; Cosgrove BP Bull World Health Organ; 1980; 58(3):423-8. PubMed ID: 6251982 [TBL] [Abstract][Full Text] [Related]
79. Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome. McKay E; Hems G; Massie A; Moffat MA; Phillips KM J Hyg (Lond); 1978 Aug; 81(1):25-30. PubMed ID: 211162 [TBL] [Abstract][Full Text] [Related]
80. Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic. Metselaar D; McDonald K; Gemert W; Nottay B; Muli JM Bull World Health Organ; 1977; 55(6):747-53. PubMed ID: 202417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]